Clinical Trial Update: Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether adding exenatide to insulin therapy improves outcomes in adults with type 2 diabetes and nonalcoholic fatty liver disease; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• Insulin (insulin)

Snippet

Sponsor: University of Florida | Conditions: Nonalcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2016-07-29